EW vs EXP · P/E 47, rev $1.39B vs P/E 16, rev $2.26B
Edwards Lifesciences Corp (EW) versus Eagle Materials Inc (EXP) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Eagle Materials Inc (EXP) is a building materials company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported EXP revenue for 2025-03-31 was $2.26B. Net income was $463.4M. Revenue was up 0.1% from 2024-03-31 to 2025-03-31. EXP currently screens at market cap $6.59B and trailing P/E 16.2.
EW currently screens at market cap $49.91B and trailing P/E 46.9. EXP currently screens at market cap $6.59B and trailing P/E 16.2.
Not investment advice. Open the EW and EXP stock pages for the full models.
Not investment advice.